Case Report
Published on 19 Jan 2023
A rare case report of waldenström macroglobulinemia converted to serum low IgM
in Genetics of Common and Rare Diseases
Frontiers in Genetics
doi 10.3389/fgene.2022.1051917
- 3,496 views
10 articles related to "Waldenstrm Macroglobulinemia"
Articles
Case Report
Published on 16 May 2025
Synchronous occurrence of Waldenström macroglobulinemia and HER2-positive gastric adenocarcinoma with gastrointestinal stromal tumor: a rare case report
in Gastrointestinal Cancers: Gastric and Esophageal Cancers
Frontiers in Oncology
doi 10.3389/fonc.2025.1554206
- 976 views
Case Report
Published on 19 Apr 2024
Case report: Waldenstrom macroglobulinemia with systemic amyloidosis as the main manifestation
in Hematology
Frontiers in Medicine
doi 10.3389/fmed.2024.1340553
- 2,169 views
Original Research
Published on 26 Jun 2023
Waldenström Macroglobulinemia diagnosis, risk assessment and treatment in Portugal – results from a Delphi-like Panel
in Blood Cancer
Frontiers in Hematology
doi 10.3389/frhem.2023.1203369
- 1,234 views
Brief Research Report
Published on 13 Sep 2023
Impact of circulating lymphoma cells at diagnosis on outcomes in patients with Waldenstrom macroglobulinemia
in Hematologic Malignancies
Frontiers in Oncology
doi 10.3389/fonc.2023.1264387
- 2,273 views
- 1 citation
Original Research
Published on 01 Jul 2025
Genomic and immune profiling of prognostic risk groups in IgM gammopathy reveals novel biomarkers beyond MYD88 L265P
in Cancer Immunity and Immunotherapy
Frontiers in Immunology
doi 10.3389/fimmu.2025.1604089
- 2,033 views
Original Research
Published on 04 May 2021
Continuous MYD88 Activation Is Associated With Expansion and Then Transformation of IgM Differentiating Plasma Cells
in B Cell Biology
Frontiers in Immunology
doi 10.3389/fimmu.2021.641692
- 7,090 views
- 14 citations
Original Research
Published on 10 Sep 2020
Trends in Incidence and Mortality of Waldenström Macroglobulinemia: A Population-Based Study
in Hematologic Malignancies
Frontiers in Oncology
doi 10.3389/fonc.2020.01712
- 9,482 views
- 17 citations
Review
Published on 16 Jul 2025
The therapeutic perspective of relapsed/refractory Waldenström Macroglobulinemia: what comes next?
in Blood Cancer
Frontiers in Hematology
doi 10.3389/frhem.2025.1624046
- 939 views
Original Research
Published on 10 May 2023
Minimal residual disease status improved the response evaluation in patients with Waldenström’s macroglobulinemia
in Cancer Immunity and Immunotherapy
Frontiers in Immunology
doi 10.3389/fimmu.2023.1171539
- 3,126 views
- 4 citations